A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Ethyl loflazepate
Temocillin
Acemetacin may decrease the excretion rate of Temocillin which could result in a higher serum level.
Ethyl loflazepate
Sultamicillin
Acemetacin may decrease the excretion rate of Sultamicillin which could result in a higher serum level.
Ethyl loflazepate
Procaine benzylpenicillin
Acemetacin may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Ethyl loflazepate
Carindacillin
Acemetacin may decrease the excretion rate of Carindacillin which could result in a higher serum level.
Ethyl loflazepate
Ticarcillin
Acemetacin may decrease the excretion rate of Ticarcillin which could result in a higher serum level.
Ethyl loflazepate
Pivmecillinam
Acemetacin may decrease the excretion rate of Pivmecillinam which could result in a higher serum level.
Ethyl loflazepate
Pivampicillin
Acemetacin may decrease the excretion rate of Pivampicillin which could result in a higher serum level.
Ethyl loflazepate
Meticillin
Acemetacin may decrease the excretion rate of Meticillin which could result in a higher serum level.
Ethyl loflazepate
Bacampicillin
Acemetacin may decrease the excretion rate of Bacampicillin which could result in a higher serum level.
Ethyl loflazepate
Metahexamide
The protein binding of Metahexamide can be decreased when combined with Acemetacin.
Ethyl loflazepate
Carbutamide
The protein binding of Carbutamide can be decreased when combined with Acemetacin.
Ethyl loflazepate
Glibornuride
The protein binding of Glibornuride can be decreased when combined with Acemetacin.
Ethyl loflazepate
Troxerutin
The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Troxerutin.
Ethyl loflazepate
Reviparin
The risk or severity of bleeding and hemorrhage can be increased when Reviparin is combined with Acemetacin.
Ethyl loflazepate
Dabigatran
The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Dabigatran.
Ethyl loflazepate
Edetate calcium disodium anhydrous
The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Edetate calcium disodium anhydrous.
Ethyl loflazepate
Tocopherylquinone
The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Tocopherylquinone.
Ethyl loflazepate
(S)-Warfarin
The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with (S)-Warfarin.
Ethyl loflazepate
Saruplase
The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Saruplase.
Ethyl loflazepate
Melagatran
The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Melagatran.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3